Beyer, KatharinaMoris, LisaLardas, MichaelHaire, AnnaBarletta, FrancescoScuderi, SimoneVradi, EleniGandaglia, GiorgioOmar, Muhammad ImranMacLennan, StevenZong, JihongFarahmand, BahmanMacLennan, Sara J.Devecseri, ZsuzsannaAsiimwe, AlexCollette, LaurenceBjartell, AndersN'Dow, JamesBriganti, AlbertoVan Hemelrijck, MiekeThe PIONEER Consortium2021-02-252021-02-252021Beyer, K, Moris, L, Lardas, M, Haire, A, Barletta, F, Scuderi, S, Vradi, E, Gandaglia, G, Omar, M I, MacLennan, S, Zong, J, Farahmand, B, MacLennan, S J, Devecseri, Z, Asiimwe, A, Collette, L, Bjartell, A, N'Dow, J, Briganti, A, Van Hemelrijck, M & The PIONEER Consortium 2021, 'Diagnostic and prognostic factors in patients with prostate cancer : a systematic review protocol', BMJ Open, vol. 11, no. 2, e040531. https://doi.org/10.1136/bmjopen-2020-0405312044-6055ORCID: /0000-0002-2691-8421/work/90172341ORCID: /0000-0002-1597-3126/work/90172594ORCID: /0000-0003-1405-6964/work/90173328ORCID: /0000-0001-5340-0081/work/162725384https://hdl.handle.net/2164/15928Funding PIONEER is funded through the IMI2 Joint Undertaking and is listed under grant agreement No. 777492. IMI2 receives support from the European Union’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA).5693696engSDG 3 - Good Health and Well-beingProstate cancerdiagnostic factorprognostic factorsUrological tumoursProstate diseaseOncologyBIASRISKoncologyPROBASTAPPLICABILITYurological tumoursTOOLprostate diseaseR Medicine (General)General MedicineR1Journal article10.1136/bmjopen-2020-040531http://www.scopus.com/inward/record.url?scp=85100831811&partnerID=8YFLogxK112